Document is current

Any future updates will be listed below

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study

Crossref DOI link: https://doi.org/10.1007/s10147-016-1041-6

Published Online: 2016-09-15

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark